Cargando…
Cancer Stem Cell Plasticity – A Deadly Deal
Intratumoral heterogeneity is a major ongoing challenge in the effective therapeutic targeting of cancer. Accumulating evidence suggests that a fraction of cells within a tumor termed Cancer Stem Cells (CSCs) are primarily responsible for this diversity resulting in therapeutic resistance and metast...
Autores principales: | Thankamony, Archana P., Saxena, Kritika, Murali, Reshma, Jolly, Mohit Kumar, Nair, Radhika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203492/ https://www.ncbi.nlm.nih.gov/pubmed/32426371 http://dx.doi.org/10.3389/fmolb.2020.00079 |
Ejemplares similares
-
Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023) -
Lineage Plasticity in Cancer: The Tale of a Skin-Walker
por: Thankamony, Archana P., et al.
Publicado: (2021) -
Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021) -
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
por: Drápela, Stanislav, et al.
Publicado: (2020) -
The Deadly Duo of COVID-19 and Cancer!
por: Bora, Vivek R., et al.
Publicado: (2021)